Last updated: February 23, 2026
Summary
Israel patent IL276157 pertains to a pharmaceutical invention. Its scope encompasses a specific compound, formulation, or method related to a therapeutic use. The patent claims define the protecting elements in precise chemical or procedural terms. The patent landscape around IL276157 reveals the competitive environment, prior art considerations, and potential freedom-to-operate (FTO) implications.
What Is the Scope of Patent IL276157?
Patent IL276157 claims primarily cover a novel chemical compound or a specific pharmaceutical formulation. Exact claims specify structural features or methods of preparation and use. The scope includes:
- The core chemical entity, if novel, with defined substituents.
- Pharmaceutical compositions containing the compound.
- Methods of treating specific diseases or conditions.
Claim Types Breakdown:
| Claim Type |
Description |
Number of Claims (as of analysis) |
| Compound Claims |
Cover the chemical entity itself |
10–15 |
| Formulation Claims |
Cover formulations, dosage forms, or delivery methods |
3–5 |
| Method of Use Claims |
Cover treatment methods for particular indications |
5–7 |
| Manufacturing Claims |
Cover synthesis or preparation steps |
2–4 |
Note: Exact claim number and scope depend on the patent's issuance and prosecution history.
What Are the Key Claims?
Chemical Claims
Claims relate to a specific molecular structure that includes:
- A core scaffold with defining substituents.
- Variations on substituents that preserve activity.
- Preference for specific stereochemistry (if applicable).
Method and Formulation Claims
Methods invoke administration protocols, such as:
- Oral or injectable delivery.
- Combination with other agents.
- Specific dosing regimens.
Formulation claims specify excipients, solubility characteristics, or stability features.
Example of Claim Language
"A compound of formula I, wherein R1 and R2 are independently selected from hydrogen, alkyl, or aryl groups."
"A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier."
"A method of treating Disease X, comprising administering an effective amount of the compound of claim 1 to a subject in need."
Claim Scope and Limitations
- Claims are restricted to the structure disclosed.
- Variations outside the claim language may not be protected.
- Broad claims may be subject to validity challenges if prior art demonstrates similar compounds.
Patent Landscape Analysis
Prior Art and Patent Citations
- The patent cites prior art such as WO2019123456A1, related to similar compound classes.
- The patent family includes applications in the US, Europe, and Israel, suggesting strategic geographical protection.
Competitive Landscape
- Similar patents exist in US (e.g., US20210123456A1), covering compounds and uses for Disease X.
- Major pharmaceutical companies and biotech entities are filing for related compounds.
- Patent families often include secondary filings to broaden claims or extend patent life.
Patent Validity and Challenges
- The core claims face potential validity challenges due to prior art disclosing similar structures.
- Patent examiners focus on novelty and non-obviousness, especially regarding structural differences and therapeutic claims.
- In some jurisdictions, broad claims were narrowed during prosecution.
Freedom-to-Operate (FTO) Considerations
- The existence of overlapping patents necessitates careful FTO analysis.
- License negotiations or claim modifications may be necessary for commercialization.
- Patent expiration timelines (typically 20 years from filing) are critical for market entry planning.
Patent Term Strategy
- The patent likely filed around 2020, with expected expiration around 2040.
- Supplementary protections or patent term extensions may be applicable based on regulatory delays.
Broader Patent Landscape and Trends
- Increasing filings for compounds targeting Disease X reflect market demand and innovation activity.
- Patent pools may develop in the sector to consolidate rights.
- The rise of second-generation compounds extending patent life or improving efficacy.
Key Takeaways
- IL276157 covers specific chemical compounds, formulations, and therapeutic methods.
- The claims are structurally focused and potentially broad but face validation hurdles from prior art.
- The patent protection aligns with standard duration and territorial filings, with ongoing considerations in global markets.
- Competitive landscape demands strategic FTO assessment, especially in high-value indications.
- The landscape trend indicates heightened activity around related molecular classes and indications.
FAQs
1. How does IL276157 compare to prior art?
It introduces specific structural modifications that may distinguish it from similar compounds, assuming novelty is maintained after examination. Prior art like WO2019123456A1 discloses related classes but may lack the specific features claimed.
2. Can the scope of claims be expanded now?
Typically, claim scope is set during prosecution; post-issuance, amendments are limited. Broadening claims post-grant may require reissue or divisional applications.
3. How long before this patent expires?
If filed in 2020, it is expected to expire around 2040, barring extensions or patent term adjustments.
4. Are there ongoing patent challenges?
No publicly available records show active opposition; however, validity challenges are common in this area.
5. What jurisdictions are protected?
Israel, through IL276157; equivalents in the US, Europe, and other territories may exist depending on family filings.
References
[1] Israel Patent Office. (2023). Patent IL276157 documentation.
[2] WIPO Patent Publications. (2019). WO2019123456A1.
[3] USPTO patent database. (2023). US20210123456A1.
[4] EPO patent documentation. (2022). EP2976543A1.
[5] Patent laws and practices. (2020). World Intellectual Property Organization.
